- NRI increased its fiscal year operating income forecast to 134.00 billion yen, compared to a previous forecast of 132.00 billion yen and an estimate of 134.62 billion yen.
- The company’s projected net income for the fiscal year is 92.00 billion yen, up from an earlier forecast of 88.00 billion yen and above an estimate of 90.56 billion yen.
- NRI anticipates net sales of 770.00 billion yen for the fiscal year, slightly lower than both the previous forecast and the estimate of 780.11 billion yen.
- The company has revised its dividend forecast to 63.00 yen, higher than a previous forecast of 58.00 yen and estimates of 59.40 yen.
- In the third quarter, NRI’s operating income surged 13% year-over-year to 36.72 billion yen, surpassing the estimate of 34.82 billion yen.
- Third-quarter net income increased by 12% year-over-year to 26.14 billion yen, exceeding the estimate of 23.57 billion yen.
- Net sales for the third quarter reached 191.47 billion yen, marking a growth of 1.9% year-over-year, although falling short of the estimate of 199.16 billion yen.
- Analyst ratings consist of 6 buys, 10 holds, and 1 sell for NRI.
Nomura Research Institute on Smartkarma
Analyst coverage on Smartkarma sheds light on recent developments involving Nomura Research Institute and other companies. In a research report by Brian Freitas titled “Nikkei 225 Index Rebalance,” it is highlighted that Nomura Research Institute and Ryohin Keikaku are set to replace Nippon Paper and DIC in the Nikkei 225 index. Additionally, the report indicates that Fast Retailing will be capped, with a CPAF drop anticipated in March. This change in composition suggests shifting positioning within the index, with implications for passive investors required to adjust their holdings accordingly.
The analysis by Brian Freitas provides insight into the dynamics of these changes, emphasizing the potential impact on market trades and positioning strategies. The detailed information on company swaps and expected CPAF adjustments offers investors valuable guidance for navigating the evolving landscape of the Nikkei 225 index. With Nomura Research Institute featuring prominently in this rebalance, investors are urged to stay informed and adapt their investment strategies to align with the evolving composition of this key market benchmark.
A look at Nomura Research Institute Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Nomura Research Institute shows a promising long-term outlook in terms of growth and resilience. With a high score of 4 in Growth, the company is anticipated to experience significant expansion in its operations and market presence over time. Coupled with a solid score of 3 in Resilience, Nomura Research Institute demonstrates capabilities to withstand challenging market conditions and maintain stability in its performance.
Although there are areas with lower scores such as Value, Dividend, and Momentum, the overall positive ratings in Growth and Resilience position Nomura Research Institute favorably for future development and sustainability in its industry.
### Nomura Research Institute, Ltd. provides information technology, research, consulting, and analyzing for business strategy decision-making. The Company also provides application software for system operation services. ###
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
